Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria

JAMA Oncol. 2023 Apr 1;9(4):455-456. doi: 10.1001/jamaoncol.2022.7170.

Authors

Trevor J Royce^{1

2}, Yihua Zhao¹, Cleo A Ryals¹

Affiliations

¹ Flatiron Health, Inc, New York, New York.
² Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

PMID: 36757717
DOI: 10.1001/jamaoncol.2022.7170

No abstract available

Plain language summary

This Viewpoint discusses the need for thoughtful, modernized eligibility criteria with equity prioritization in clinical trials.

MeSH terms

Eligibility Determination*
Humans
Patient Selection